{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:18:40Z","timestamp":1759990720603},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[1994,1]]},"DOI":"10.1016\/0959-8049(94)90243-7","type":"journal-article","created":{"date-parts":[[2004,4,17]],"date-time":"2004-04-17T23:13:19Z","timestamp":1082243599000},"page":"289-294","source":"Crossref","is-referenced-by-count":11,"title":["Phase I and pharmacological study of intra-arterial hepatic administration of pirarubicin in patients with advanced hepatic metastases"],"prefix":"10.1016","volume":"30","author":[{"given":"Jean-Nicolas","family":"Munck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Rougier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy G.","family":"Chabot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis H.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Bognel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Lumbroso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Herait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Elias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Lasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Gouyette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0959-8049(94)90243-7_BIB1","first-page":"31","article-title":"Intraarterial infusion of anticancer drugs: theoretical aspects of drug delivery and review of response","volume":"64","author":"Chen","year":"1980","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/0959-8049(94)90243-7_BIB2","first-page":"176","article-title":"Clinical pharmacology of hepatic arterial chemotherapy","volume":"2","author":"Ensminger","year":"1983","journal-title":"Sem Oncol"},{"key":"10.1016\/0959-8049(94)90243-7_BIB3","first-page":"101","article-title":"Regional cancer chemotherapy","volume":"68","author":"Ensminger","year":"1984","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/0959-8049(94)90243-7_BIB4","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/1097-0142(19870501)59:9<1547::AID-CNCR2820590903>3.0.CO;2-6","article-title":"Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein","volume":"59","author":"Ridge","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(94)90243-7_BIB5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1200\/JCO.1985.3.1.98","article-title":"Biliary sclerosis in patients receiving hepatic intraarterial infusion of floxuridine","volume":"3","author":"Hohn","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(94)90243-7_BIB6","first-page":"125","article-title":"Etude anatomo-pathologique de la toxicit\u00e9 de la chimioth\u00e9rapie intra-art\u00e9rielle h\u00e9patique","volume":"13","author":"Bognel","year":"1989","journal-title":"Gastroent\u00e9rol Clin Biol"},{"key":"10.1016\/0959-8049(94)90243-7_BIB7","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.1992.10.7.1112","article-title":"Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial","volume":"7","author":"Rougier","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(94)90243-7_BIB8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/1097-0142(197808)42:2<399::AID-CNCR2820420204>3.0.CO;2-5","article-title":"Intraarterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma. A clinical and pharmacological report","volume":"42","author":"Bern","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(94)90243-7_BIB9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02934780","article-title":"Intrahepatic and intravenous administration of adriamycin. A comparative pharmacokinetic study in patients with malignant liver tumours","volume":"2","author":"Eksborg","year":"1985","journal-title":"Med Oncol Tumor Pharmacother"},{"key":"10.1016\/0959-8049(94)90243-7_BIB10","first-page":"4105","article-title":"A clinical-pharmacological evaluation of hepatic arterial infusion of adriamycin","volume":"39","author":"Garnick","year":"1979","journal-title":"Cancer Res"},{"key":"10.1016\/0959-8049(94)90243-7_BIB11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF00252979","article-title":"Hepatic extraction, metabolism and biliary excretion of doxorubicin in the isolated perfused rat liver","volume":"19","author":"Ballet","year":"1987","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/0959-8049(94)90243-7_BIB12","first-page":"1565","article-title":"Preliminary experiences with intraarterial adriamycin","volume":"8","author":"Shah","year":"1977","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/0959-8049(94)90243-7_BIB13","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/0277-5379(86)90138-0","article-title":"Intrahepatic arterial administration of 4\u2032 epidoxorubicin (Epirubicin) in advanced cancer patients. A pharmacokinetic study","volume":"2","author":"Panuti","year":"1986","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/0959-8049(94)90243-7_BIB14","first-page":"1670","article-title":"Pirarubicin (THP-adriamycin) efficacy in breast cancer and safety in phase II studies. Comparison with published data on similar compounds is a crucial decision point for further development of a new anticancer drug","volume":"28A","author":"H\u00e9rait","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1016\/0959-8049(94)90243-7_BIB15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0145-2126(85)90091-8","article-title":"Relationship between the intracellular level and growth inhibition of a new anthracycline 4\u2032-O-tetrahydropyranyl adriamycin in Friend leukemia cell variants","volume":"2","author":"Munck","year":"1985","journal-title":"Leuk Res"},{"key":"10.1016\/0959-8049(94)90243-7_BIB16","series-title":"Progress in Cancer Chemoimmunotherapy","first-page":"55","article-title":"Plasma and cellular levels of adriamycin and 4\u2032-O-tetrahydropyranyl-adriamycin in humans","author":"Munck","year":"1984"},{"key":"10.1016\/0959-8049(94)90243-7_BIB17","first-page":"1","article-title":"Pharmacokinetic and pharmacodynamic advantage of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model","volume":"53","author":"Munck","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/0959-8049(94)90243-7_BIB18","series-title":"Pharmacokinetics","author":"Gibaldi","year":"1982"},{"key":"10.1016\/0959-8049(94)90243-7_BIB19","first-page":"1231","article-title":"Phase II pirarubicin (THP-ADM) of the clinical screening group of the EORTC. Updated results","volume":"31","author":"Schneider","year":"1990"},{"key":"10.1016\/0959-8049(94)90243-7_BIB20","first-page":"438","article-title":"Phase II trial of intraarterial THP-adriamycin for metastatic colorectal cancer confined to the liver","volume":"9","author":"Munck","year":"1990"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0959804994902437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0959804994902437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T08:58:30Z","timestamp":1682672310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0959804994902437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,1]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1994,1]]}},"alternative-id":["0959804994902437"],"URL":"https:\/\/doi.org\/10.1016\/0959-8049(94)90243-7","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[1994,1]]}}}